lCAUTIONSModerate to severe acute infection.moderate
to severe febrile illness.serum-palivizumab concentration
may be reduced after cardiac surgery.thrombocytopenia
lSIDE-EFFECTS
▶Common or very commonApnoea
▶UncommonSeizure.thrombocytopenia.urticaria
▶Frequency not knownHypersensitivity
lALLERGY AND CROSS-SENSITIVITYHypersensitivity to
humanised monoclonal antibodies.
lMEDICINAL FORMS
There can be variation in the licensing of different medicines
containing the same drug.
Solution for injection
▶Synagis(AbbVie Ltd)
Palivizumab 100 mg per 1 mlSynagis 100 mg/ 1 ml solution for
injection vials| 1 vialP£ 563. 64
Synagis 50 mg/ 0. 5 ml solution for injection vials| 1 vialP£ 306. 34
BNFC 2018 – 2019 Respiratory syncytial virus 431
Infection5